Collective Family Office LLC Buys 2,750 Shares of Patterson Companies, Inc. (NASDAQ:PDCO)

Collective Family Office LLC grew its stake in shares of Patterson Companies, Inc. (NASDAQ:PDCO) by 29.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 12,047 shares of the company’s stock after acquiring an additional 2,750 shares during the period. Collective Family Office LLC’s holdings in Patterson Companies were worth $401,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Sound Income Strategies LLC grew its position in shares of Patterson Companies by 8.2% during the 2nd quarter. Sound Income Strategies LLC now owns 423,535 shares of the company’s stock valued at $14,087,000 after acquiring an additional 32,211 shares during the period. Duality Advisers LP bought a new position in shares of Patterson Companies during the 1st quarter valued at approximately $1,138,000. ProShare Advisors LLC grew its position in shares of Patterson Companies by 22.5% during the 1st quarter. ProShare Advisors LLC now owns 20,267 shares of the company’s stock valued at $543,000 after acquiring an additional 3,716 shares during the period. Toroso Investments LLC grew its position in shares of Patterson Companies by 8.6% during the 1st quarter. Toroso Investments LLC now owns 35,426 shares of the company’s stock valued at $948,000 after acquiring an additional 2,796 shares during the period. Finally, Trivant Custom Portfolio Group LLC purchased a new stake in shares of Patterson Companies during the 1st quarter valued at approximately $60,000. 79.24% of the stock is owned by institutional investors.

Insider Activity at Patterson Companies

In related news, CEO Donald Zurbay sold 5,620 shares of Patterson Companies stock in a transaction on Tuesday, July 18th. The shares were sold at an average price of $32.48, for a total value of $182,537.60. Following the transaction, the chief executive officer now owns 149,539 shares in the company, valued at approximately $4,857,026.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CEO Donald Zurbay sold 5,620 shares of Patterson Companies stock in a transaction on Tuesday, July 18th. The shares were sold at an average price of $32.48, for a total value of $182,537.60. Following the transaction, the chief executive officer now owns 149,539 shares in the company, valued at approximately $4,857,026.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Les B. Korsh sold 3,500 shares of Patterson Companies stock in a transaction on Wednesday, June 21st. The stock was sold at an average price of $31.75, for a total transaction of $111,125.00. Following the completion of the transaction, the insider now owns 67,949 shares in the company, valued at approximately $2,157,380.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,380 shares of company stock valued at $496,590. Insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on PDCO. StockNews.com cut shares of Patterson Companies from a “buy” rating to a “hold” rating in a research note on Thursday, September 7th. Bank of America upped their price target on shares of Patterson Companies from $35.00 to $40.00 in a research note on Thursday, June 22nd. Piper Sandler upped their price target on shares of Patterson Companies from $35.00 to $39.00 in a research note on Thursday, June 22nd. Stifel Nicolaus restated a “hold” rating and set a $32.00 price target on shares of Patterson Companies in a research note on Thursday, August 31st. Finally, Robert W. Baird increased their target price on shares of Patterson Companies from $31.00 to $35.00 in a research note on Thursday, June 22nd. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Patterson Companies presently has an average rating of “Moderate Buy” and an average price target of $35.83.

Patterson Companies Price Performance

NASDAQ PDCO traded down $0.05 on Monday, hitting $28.29. The stock had a trading volume of 205,693 shares, compared to its average volume of 781,675. Patterson Companies, Inc. has a 52-week low of $23.87 and a 52-week high of $34.53. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.79 and a current ratio of 1.63. The company has a market capitalization of $2.71 billion, a price-to-earnings ratio of 12.94, a price-to-earnings-growth ratio of 1.24 and a beta of 1.32. The firm has a 50-day moving average of $32.13 and a 200-day moving average of $29.17.

Patterson Companies (NASDAQ:PDCO) last issued its quarterly earnings results on Wednesday, August 30th. The company reported $0.40 EPS for the quarter, hitting analysts’ consensus estimates of $0.40. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.58 billion. Patterson Companies had a net margin of 3.28% and a return on equity of 22.24%. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.32 EPS. Equities analysts expect that Patterson Companies, Inc. will post 2.5 EPS for the current year.

Patterson Companies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Stockholders of record on Friday, October 20th will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 3.68%. The ex-dividend date of this dividend is Thursday, October 19th. Patterson Companies’s payout ratio is 47.49%.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.